Hypoxia-induced cell stemness leads to drug resistance and poor prognosis in lung adenocarcinoma
Mingchuan Zhao(Tongji University), Caicun Zhou(Tongji University), Gang Zeng(Sun Yat-sen University), Xi Chen(Tongji University), Gentao Liu(Tongji University), Mengmeng Zhang(Sun Yat-sen University), Shaohua Wang(Hebei Medical University), Huijun Zhang(Fudan University), Heyong Wang(Tongji University), Xiaofeng Chen(Shanghai Pulmonary Hospital), Yishi Zhang(Children's Hospital of Chongqing Medical University)
Cited by 69
Related Papers
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
|Molecular Cancer|2006|1.8k
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet Oncology|2022|417
Deep learning for autonomous ship-oriented small ship detection
|Safety Science|2020|207